|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents ($5.9 million and $6.9 million restricted from use at September 30, 2023 and December 31, 2022, respectively) | ||||||||||||||||||||
| Fees receivable, net of allowance for doubtful accounts of $0.0 million and $0.1 million at September 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Property and equipment, net of accumulated depreciation of $18.1 million and $15.6 million at September 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Operating lease right-of-use asset | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Compensation payable | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Current income taxes payable | ||||||||||||||||||||
| Operating lease obligations | ||||||||||||||||||||
| Secured promissory note | ||||||||||||||||||||
| Secured term loan payable | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Common stock, par value $0.01 per share; 100,000,000 shares authorized, 55,321,470 and 53,288,909 shares issued as of September 30, 2023 and December 31, 2022, respectively; 18,815,295 and 17,768,705 shares outstanding as of September 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Restricted stock units | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Treasury stock, par value (usd per share) | ||||||||||||||||||||
| Treasury Stock, Common, Shares | ||||||||||||||||||||
| Treasury stock, at cost, par value $0.01 per share; 36,499,038 and 35,520,204 shares as of June 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Treasury stock, at cost, par value $0.01 per share; 36,506,175 and 35,520,204 shares as of September 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
